Insider Stock Trading History of Freiman Paul E


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Freiman Paul E since year 2005. The trader's CIK number is 1184160. At the time of this reporting, Freiman Paul E is the Other of Penwest Pharmaceuticals Co . (stock ticker symbol PPCO). See this page for all insider trading activities at Penwest Pharmaceuticals Co .

Note that in the past FREIMAN PAUL E also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Freiman Paul E since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2009-09-03 PPCO Penwest Pharmaceuticals Co Sale 3,466 2.35 8,145
2008-12-10 NTII Neurobiological Technologies Inc /ca/ Sale 1,000 .61 610
2008-12-16 NTII Neurobiological Technologies Inc /ca/ Sale 1,000 .57 570
2008-12-17 NTII Neurobiological Technologies Inc /ca/ Sale 466 .21 97
2008-06-10 PPCO Penwest Pharmaceuticals Co Sale 5,000 3.08 15,425
2008-05-12 PPCO Penwest Pharmaceuticals Co Sale 4,000 2.64 10,540
2007-12-03 NTII Neurobiological Technologies Inc /ca/ Buy 3,000 3.30 9,900
2007-08-07 PPCO Penwest Pharmaceuticals Co Option Ex 4,489 6.12 27,472
2007-05-29 PPCO Penwest Pharmaceuticals Co Option Ex 1,999 7.51 15,012
2007-02-21 NTII Neurobiological Technologies Inc /ca/ Sale 35,437 2.73 96,672
2007-02-22 NTII Neurobiological Technologies Inc /ca/ Sale 64,563 2.61 168,509
2007-02-21 NTII Neurobiological Technologies Inc /ca/ Option Ex 35,437 1.88 66,444
2007-02-22 NTII Neurobiological Technologies Inc /ca/ Option Ex 109,563 1.75 191,735
2006-05-01 PPCO Penwest Pharmaceuticals Co Sale 10,000 19.90 199,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Freiman Paul E (Other of Penwest Pharmaceuticals Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.